Analystreport

Unity Biotechnology, Inc. (NASDAQ: UBX) had its price target lowered by analysts at Wedbush from $35.00 to $5.00.

Unity Biotechnology, Inc.  (UBX) 
Last unity biotechnology, inc. earnings: 3/11 04:05 pm Check Earnings Report